Haibo Ma
Shandong University(CN)
Publications by Year
Research Areas
Lung Cancer Diagnosis and Treatment, Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, Esophageal and GI Pathology, Cancer-related molecular mechanisms research
Most-Cited Works
- → pH‐sensitive carbon quantum dots−doxorubicin nanoparticles for tumor cellular targeted drug delivery(2019)56 cited
- → microRNA-301b-3p downregulation underlies a novel inhibitory role of long non-coding RNA MBNL1-AS1 in non-small cell lung cancer(2019)47 cited
- → CircSCN8A suppresses malignant progression and induces ferroptosis in non-small cell lung cancer by regulating miR-1290/ACSL4 axis(2022)38 cited
- → Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial(2024)30 cited
- → LncRNA SNHG15 contributes to doxorubicin resistance of osteosarcoma cells through targeting the miR-381-3p/GFRA1 axis(2020)29 cited
- → pH-responsive mesoporous silica drug delivery system for targeted cancer chemotherapy(2020)26 cited
- → THAP9-AS1/miR-133b/SOX4 positive feedback loop facilitates the progression of esophageal squamous cell carcinoma(2021)25 cited
- → Comparison of outcomes of open and minimally invasive esophagectomy in 183 patients with cancer.(2014)24 cited
- → The clinical significance of subcarinal lymph node dissection in the radical resection of oesophageal cancer(2013)16 cited
- → Circ_0007624 suppresses the development of esophageal squamous cell carcinoma via targeting miR-224-5p/CPEB3 to inactivate the EGFR/PI3K/AKT signaling(2022)15 cited